Adoptive transfer of CD4(+) T cells specific for subunit A of Helicobacterpylori urease reduces H-pylori stomach colonization in mice in the absenceof interleukin-4 (IL-4)/IL-13 receptor signaling
B. Lucas et al., Adoptive transfer of CD4(+) T cells specific for subunit A of Helicobacterpylori urease reduces H-pylori stomach colonization in mice in the absenceof interleukin-4 (IL-4)/IL-13 receptor signaling, INFEC IMMUN, 69(3), 2001, pp. 1714-1721
Protection in the murine model of Helicobacter pylori infection may be medi
ated by CD4(+) T cells, but the mechanism remains unclear. To better unders
tand how protection occurs in this model, we generated and characterized H.
pylori urease-specific CD4(+) T cells from BALB/c mice immunized with Salm
onella enterica serovar Typhimurium expressing H. pylori urease (subunits A
and B), The CD4(+) T tells were found to be specific for subunit A (UreA).
Upon antigen-specific stimulation, expression of interleukin 4 (IL-4), IL-
10, gamma interferon (INF-gamma), and tumor necrosis factor alpha was induc
ed. Immunocytochemical analysis showed that the majority of cells produced
IFN-gamma and IL-10, Adoptive transfer of the UreA-specific CD4(+) T cells
into naive syngeneic recipients led to a threefold reduction in the number
of bacteria in the recipient group when compared to that in the nonrecipien
t group. Stomach colonization was also reduced significantly after transfer
of these cells into patently infected mice. Adoptive transfer of UreA-spec
ific CD4(+) T cells into IL-4 receptor alpha chain-deficient BALB/c mice in
dicated that IL-4 and IL-13 were not critical in the control of bacterial l
oad. In addition, synthetic peptides were used to identify three functional
T-cell epitopes present in subunit A which were recognized by the UreA-spe
cific T cells. Analysis of H, pylori-specific cellular immune responses in
recipient challenged and nonrecipient infected mice indicated a strong loca
l restriction of the response in infected animals. The implications of thes
e findings for the mechanism of protection and the development of peptide b
ased vaccination are discussed.